- ►physiology.org MJ Dunne, KE Cosgrove, RM Shepherd, A … - Physiological reviews, 2004 - Am Physiological Soc The earliest description of hyperinsulinism appears to have been that provided
by Laidlaw in 1938 who used the term nesidioblastosis to describe the severe,
recurrent hypoglycemia associated with an inappropriate elevation of serum ... Cited by 107 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org U Matzner, E Herbst, KK Hedayati, R Lullmann … - Human molecular genetics, 2005 - Oxford Univ Press A deficiency of arylsulfatase A (ASA) causes the lysosomal storage disease
metachromatic leukodystrophy, which is characterized by accumulation of the
sphingolipid 3-O-sulfogalactosylceramide (sulfatide). Sphingolipid storage ... Cited by 53 - Related articles - All 6 versions
- ►nih.gov HL Olsen, M Høy, W Zhang, AM Bertorello, K … - Proceedings of the National Academy of Sciences of …, 2003 - National Acad Sciences Insulin secretion is controlled by the β cell′s metabolic state, and the
ability of the secretory granules to undergo exocytosis increases during glucose
stimulation in a membrane potential-independent fashion. Here, we ... Cited by 38 - Related articles - BL Direct - All 8 versions
K Buschard, M Blomqvist, T Osterbye, P … - Diabetologia, 2005 - Springer Abstract Mammalian tissues express β-isoforms of gly- cosphingolipids and,
among these, sulfatide (sulphated galactosylceramide) is present in the beta
cells, and it is here that the short fatty acid chain (C16) isoform is pre- ... Cited by 10 - Related articles - BL Direct - All 3 versions
- ►cjb.net M Eckhardt, KK Hedayati, J Pitsch, R … - Journal of Neuroscience, 2007 - neuro.cjb.net Metachromatic leukodystrophy is a lysosomal storage disorder caused by
deficiency in the sulfolipid degrading enzyme arylsulfatase A (ASA). In the
absence of a functional ASA gene, 3-O-sulfogalactosylceramide (sulfatide; ... Cited by 9 - Related articles - All 4 versions
M Blomqvist, T Osterbye, JE Mansson, T … - Apmis, 2003 - interscience.wiley.com Sulfatide (3'-sulfogalactosyl-ceramide) is a glycosphingolipid mainly located in
the nervous system, but has also been found in the islets of Langerhans.
Previous studies have suggested that sulfatide is involved in insulin ... Cited by 8 - Related articles - BL Direct - All 5 versions
K Buschard, P Fredman, E Bog-Hansen, M … - Diabetic Medicine, 2005 - interscience.wiley.com Aims The glycosphingolipid sulfatide (sulfated galactosyl-ceramide) increases
exocytosis of β-cell secretory granules, activates K ATP -channels and is
thereby able to influence insulin secretion through its presence in the ... Cited by 6 - Related articles - BL Direct - All 4 versions
M Blomqvist, M Carrier, T Andrews, K … - Diabetes/Metabolism Reviews - interscience.wiley.com Sulfatide is present in the secretory granules of beta cells and has been shown,
in vitro, to be involved in insulin processing and secretion. Of particular
interest is one of the major sulfatide isoforms in the beta cells, the ... Cited by 6 - Related articles - All 2 versions
- ►diabetesjournals.org K Buschard, M Blomqvist, JE Månsson, P … - Diabetes, 2006 - Am Diabetes Assoc Sulfatide (3′-sulfo-β-galactosyl ceramide) is a glycosphingolipid present in
mammalians in various fatty acid isoforms of which the saturated 16 carbon-atom
length (C16:0) is more abundant in pancreatic islets than in neural tissue, ... Cited by 6 - Related articles - BL Direct - All 6 versions
M Blomqvist, T Osterbye, JE Månsson, T … - Glycoconjugate Journal, 2002 - Springer Glycoconjugate Journal 19, 403–413, 2003 C 2003 Kluwer Academic Publishers.
Manufactured in The Netherlands. ... Sulfatide is associated with insulin
granules and ... Maria Blomqvist1, Thomas Osterbye2, Jan-Eric Månsson1, ... Cited by 4 - Related articles - BL Direct - All 3 versions
